Members |
targetComponentId |
cervixutstryk, avböjt |
Screening for malignant neoplasm of cervix declined (situation) |
Cervical smear refused |
Screening for malignant neoplasm of cervix declined (situation) |
Cervical smear refused |
Screening for malignant neoplasm of cervix declined (situation) |
cervikal spondylos med myelopati |
Myelopathy due to cervical spondylosis (disorder) |
Cervical spondylosis with myelopathy |
Myelopathy due to cervical spondylosis (disorder) |
cervikal spondylos med radikulopati |
Radiculopathy due to cervical spondylosis (disorder) |
Cervical syndrome, NEC |
Cervical syndrome |
Cervicitis |
Inflammation of cervix |
Cervus elaphus bactrianus |
Cervus elaphus |
Cervus elaphus nannodes |
Cervus elaphus |
Cesarean delivery without indication |
Cesarean section |
cetirizinhydroklorid + pseudoefedrin 5 mg/120 mg, tablett med modifierad frisättning |
Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form) |
cetirizinhydroklorid 5 mg + pseudoefedrin 120 mg, depåtablett |
Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form) |
cetirizinhydroklorid 5 mg/5 ml, sirap |
Cetirizine hydrochloride 1 mg/mL oral solution |
Cetirizine hydrochloride 5mg/5mL syrup |
Cetirizine hydrochloride 1 mg/mL oral solution |
Cetirizine hydrochloride+pseudoephedrine hydrochloride 5mg/120mg m/r tablet |
Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form) |
cetylalkohol 12 mg + kolfoscerilpalmitat 108 mg + tyloxapol 8 mg, pulver |
Product containing only cetyl alcohol and colfosceril and tyloxapol (medicinal product) |
cetyldimetikon 5 %, badolja |
Cetyl dimeticone 50 mg/mL cutaneous oil |
utmanande miljö |
Challenging environment |
kamomillextrakt 10,5 %, salva |
Product containing only chamomile extract (medicinal product) |
Chancre of yaws |
Initial lesion of yaws |
kaotisk miljö |
Chaotic environment (finding) |
Chaperone refused |
Provision of chaperone declined |
förkläde avböjt |
Provision of chaperone declined |
Chaperone refused |
Provision of chaperone declined |
egenskap som rör psykologisk perception |
Characteristic of perception |
Chediak-Higashi syndrome |
Chédiak-Higashi syndrome |
Chemical element AND/OR compound |
Chemical categorized by structure (substance) |
kemiskt medel eller yttre faktor |
Substance |
körsbär, livsmedel |
Cherry (substance) |
Chickenpox with other specified complications |
Chickenpox with complication |
Chikungunya hemorrhagic fever |
Chikungunya fever |
Chilblain lupus erythematosus |
Sarcoidosis, lupus pernio type |
Chilognatha |
Class Diplopoda (organism) |
kinarestaurangsyndromet |
Monosodium glutamate symptom complex |
DNA från Chlamydia pneumoniae |
Chlamydophila pneumoniae DNA |
kloralhydrat 250 mg/5 ml, sirap |
Chloral hydrate 50 mg/mL oral solution |
kloralhydrat 10 g, suppositorium |
Chloral hydrate 650 mg rectal suppository |
kloralhydrat 5 g, suppositorium |
Chloral hydrate 325 mg rectal suppository |
kloralsedativ |
Chloral derivative (substance) |
kloramin T-specifikt extrakt |
Product containing tosylchloramide sodium (medicinal product) |
kloramfenikolantibiotika |
Chloramphenicol (substance) |
kloramfenikol 0,25 %, ögondroppar |
Chloramphenicol (as chloramphenicol sodium succinate) 2.5 mg/mL eye solution |
Chlorhexidine |
Product containing chlorhexidine (medicinal product) |
klorhexidindiglukonat 0,05 % + ametokain 0,015 %, oral sprej |
Chlorhexidine gluconate 500 microgram/mL and tetracaine 150 microgram/mL oral spray |
klorhexidinglukonat 0,02 % i 70 % IMS, sprej |
Chlorhexidine gluconate 200 microgram/mL cutaneous spray |
Chlorhexidine gluconate 0.02% in 70% IMS spray refill |
Chlorhexidine gluconate 200 microgram/mL cutaneous spray |
klorhexidinglukonat 0,5 % i 70 % IMS, lösning |
Chlorhexidine gluconate 50 mg/mL cutaneous solution |
klorhexidinglukonat 0,5 % i 70 % IMS, sprej |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Chlorhexidine gluconate 0.5% in 70% IMS spray refill |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
klorhexidinglukonat 2 % / isopropanol 70 %, svamp för lokalt bruk |
Product containing only chlorhexidine and isopropyl alcohol (medicinal product) |
klorhexidinglukonat 3,15 % / isopropanol 70 %, kompress för lokalt bruk |
Product containing only chlorhexidine and isopropyl alcohol (medicinal product) |
klorhexidinglukonat 1 % + etylalkohol 61 %, lösning |
Product containing only chlorhexidine and ethanol (medicinal product) |
klorhexidinglukonat 0,2 % + lidokainhydroklorid 0,05 %, munhålesprej |
Product containing only chlorhexidine and lidocaine (medicinal product) |
klorhexidinglukonat 0,2 % + lidokainhydroklorid 0,05 %, svalgsprej |
Product containing only chlorhexidine and lidocaine (medicinal product) |
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray |
Product containing only chlorhexidine and lidocaine (medicinal product) |
Chlorhexidine gluconate+lignocaine hydrochloride 0.2%/0.05% throat spray |
Product containing only chlorhexidine and lidocaine (medicinal product) |
klorhexidinglukonat 0,5 % / natriumnitrit 0,1 % i 70 % IMS, lösning |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Chlorhexidine hydrochloride+neomycin sulfate |
Product containing chlorhexidine and neomycin (medicinal product) |
biverkning av desinfektionsmedel med klorerad fenol |
Chlorinated phenol adverse reaction |
allergi mot desinfektionsmedel innehållande klorerad fenol |
Allergy to chlorinated phenol (finding) |
kloroformsubstans som missbrukas, icke läkemedel |
Chloroform |
Chlorophenothane |
Clofenotane |
kloroprokainhydroklorid 1 %, injektionsvätska, lösning, ampull |
Product containing only chloroprocaine (medicinal product) |
kloroprokainhydroklorid 2 %, injektionsvätska, lösning, ampull |
Product containing only chloroprocaine (medicinal product) |
kloroprokainhydroklorid 3 %, injektionsvätska, lösning, ampull |
Product containing only chloroprocaine (medicinal product) |
Chloroxylenol |
Chloroxylenol (substance) |
klorfeniramin 2 mg + ibuprofen 200 mg + pseudoefedrin 30 mg, kapsel |
Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
klorfenamin 2 mg + ibuprofen 200 mg + pseudoefedrin 30 mg, tablett |
Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
Chlorpheniramine maleate |
Product containing chlorphenamine (medicinal product) |
klorfeniraminmaleat + metskopolaminnitrat + pseudoefedrinhydroklorid 8 mg/2,5 mg/120 mg, tablett med modifierad frisätttning |
Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form) |
klorfenaminmaleat 8 mg + metskopolaminnitrat 2,5 mg + pseudoefedrinhydroklorid 120 mg, depåtablett |
Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form) |
Chlorpheniramine maleate + pseudoephedrine hydrochloride |
Product containing chlorphenamine and pseudoephedrine (medicinal product) |
klorfeniraminmaleat + fenylefrinhydroklorid + fenyltoloxamincitrat 4 mg/20 mg/50 mg, kapsel med modifierad frisättning |
Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form |
klorfenaminmaleat 4 mg + fenylefrinhydroklorid 20 mg + fenyltoloxamincitrat 50 mg, depåkapsel |
Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form |
klorpromazinhydroklorid 10 mg/5 ml, sirap |
Chlorpromazine hydrochloride 2 mg/mL oral solution |
klorpromazinhydroklorid 150 mg, kapsel med modifierad frisättning |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
klorpromazinhydroklorid 150 mg, depåkapsel |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
klorpromazinhydroklorid 30 mg, kapsel med modifierad frisättning |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
klorpromazinhydroklorid 30 mg, depåkapsel |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
klorpromazinhydroklorid 50 mg/5 ml, sirap |
Product containing precisely chlorpromazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
klorpromazinhydroklorid 75 mg, kapsel med modifierad frisättning |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
klorpromazinhydroklorid 75 mg, depåkapsel |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
Chlorprothixene overdose |
Chlorprothixene overdose (disorder) |
klortetracyklinhydroklorid 3 %, salva |
Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
kolesterolanalyt |
Cholesterol |
avböjt deltagande i program med kolesterolsänkande kost |
Cholesterol reduction programme declined |
kolestyramin + sackaros |
Product containing colestyramine (medicinal product) |
kolestyramin 4 g, pulver |
Colestyramine 4 g powder for oral suspension sachet |
Cholestyramine 4g suspension |
Colestyramine 4 g powder for oral suspension sachet |
Cholestyramine 4g/unit powder |
Colestyramine 4 g powder for oral suspension sachet |
Cholestyramine 4g/unt powder |
Colestyramine 4 g powder for oral suspension sachet |
kolestyramin + aspartam |
Product containing colestyramine (medicinal product) |
kolestyramin + aspartam, dospåse 4 g, pulver |
Colestyramine 4 g powder for oral suspension sachet |
kolinsalicylat 20 % + glycerol 12,6 %, örondroppar |
Product containing precisely choline 200 milligram/1 milliliter and glycerol 126 milligram/1 milliliter conventional release ear solution (clinical drug) |
kolinteofyllinatallergi |
Allergy to theophylline (finding) |
Chondrocyte cell |
Chondrocyte (substance) |
kondrosarkom, kategori |
Chondrosarcoma |
kondrosarkom |
Chondrosarcoma |
koriokarcinom |
Choriocarcinoma (morphologic abnormality) |
koriongonadotropin alfa 10 000 IE, pulver och vätska till injektionslösning, ampull |
Choriogonadotropin alfa only product in parenteral dose form |